1 274 108 ADDITIONAL BENEFIT OF YOGA TO STANDARD LIFESTYLE MODIFICATION ON BLOOD PRESSURE IN PREHYPERTENSIVE SUBJECTS: A RANDOMIZED CONTROLLED STUDY. HIGH BLOOD PRESSURE (BP) IS A KNOWN RISK FACTOR FOR CARDIOVASCULAR DISEASE MORBIDITY. CONSIDERING THE GROWING EVIDENCE OF NONPHARMACOLOGICAL INTERVENTIONS IN THE MANAGEMENT OF HIGH BP, WE DESIGNED A RANDOMIZED, PARALLEL ACTIVE-CONTROLLED STUDY ON THE EFFECT OF YOGA AND STANDARD LIFESTYLE MODIFICATION (LSM) ON BP AND HEART RATE IN INDIVIDUALS WITH PREHYPERTENSION (SYSTOLIC BP 120-139 MM HG AND/OR DIASTOLIC BP 80-89 MM HG). VOLUNTEERS (20-60 YEARS) OF BOTH GENDERS WITHOUT ANY KNOWN CARDIOVASCULAR DISEASE WERE RANDOMIZED INTO EITHER LSM GROUP (N = 92) OR LSM+YOGA GROUP (N = 92). BEFORE THE INTERVENTION, AGE, WAIST CIRCUMFERENCE, PHYSICAL ACTIVITY, BP AND FASTING PLASMA GLUCOSE AND LIPIDS WERE COMPARABLE BETWEEN THE GROUPS. AFTER 12 WEEKS OF INTERVENTION, WE OBSERVED A SIGNIFICANT REDUCTION IN THE BP AND HEART RATE IN BOTH THE GROUPS. FURTHER, THE REDUCTION IN SYSTOLIC BP WAS SIGNIFICANTLY MORE IN LSM+YOGA GROUP (6 MM HG) AS COMPARED WITH LSM GROUP (4 MM HG). IN ADDITION, 13 PREHYPERTENSIVES BECAME NORMOTENSIVES IN LSM+YOGA GROUP AND FOUR IN LSM GROUP. THE RESULTS INDICATE EFFICACY OF NONPHARMACOLOGICAL INTERVENTION AND THE ADDITIONAL BENEFIT OF YOGA TO STANDARD LSM. FURTHER RESEARCH IN THIS FIELD MAY ADD TO THE LEVEL OF EVIDENCE ON THE BENEFIT OF YOGA, IN THE REDUCTION OF BP IN HIGH BP SUBJECTS, IN THE SCIENTIFIC LITERATURE. 2015 2 1933 35 ROLE OF YOGA IN MODIFYING CERTAIN CARDIOVASCULAR FUNCTIONS IN TYPE 2 DIABETIC PATIENTS. OBJECTIVES: 1. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON CARDIAC FUNCTIONS IN TYPE 2 DIABETICS. 2. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON BLOOD GLUCOSE LEVEL, GLYCOSYLATED HEMOGLOBIN. METHODS: THE PRESENT STUDY DONE IN TWENTY-FOUR TYPE 2 DM CASES PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND AUTONOMIC FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH AUTONOMIC FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND THEY PURSUED THOSE 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. RESULTS: THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS FROM BASAL 190.08 +/- 18.54 IN MG/DL TO 141.5 +/- 16.3 IN MG/DL AFTER YOGA REGIMEN. THE POST PRANDIAL BLOOD GLUCOSE LEVELS DECREASED FROM 276.54 +/- 20.62 IN MG/DL TO 201.75 +/- 21.24 IN MG/DL, GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE FROM 9.03 +/- 0.29% TO 7.83 +/- 0.53% AFTER YOGA REGIMEN. THE PULSE RATE, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE DECREASED SIGNIFICANTLY (FROM 86.45 +/- 2.0 TO 77.65 +/- 2.5 PULSE/MIN, FROM 142.0 +/- 3.9 TO 126.0 +/- 3.2 MM OF HG AND FROM 86.7 +/- 2.5 MM OF HG TO 75.5 +/- 2.1 MM OF HG AFTER YOGA REGIMEN RESPECTIVELY). CORRECTED QT INTERVAL (QTC) DECREASED FROM 0.42 +/- 0.0 TO 0.40 +/- 0.0. CONCLUSION: THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND STABLE AUTONOMIC FUNCTIONS CAN BE OBTAINED IN TYPE 2 DM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND AUTONOMIC FUNCTIONS REMAINS TO BE WORKED OUT. 2004 3 2491 40 YOGA AS ANTIHYPERTENSIVE LIFESTYLE THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: TO INVESTIGATE THE EFFICACY OF YOGA AS ANTIHYPERTENSIVE LIFESTYLE THERAPY AND IDENTIFY MODERATORS THAT ACCOUNT FOR VARIABILITY IN THE BLOOD PRESSURE (BP) RESPONSE TO YOGA. METHODS: WE SYSTEMATICALLY SEARCHED 6 ELECTRONIC DATABASES FROM INCEPTION THROUGH JUNE 4, 2018, FOR ARTICLES PUBLISHED IN ENGLISH LANGUAGE JOURNALS ON TRIALS OF YOGA INTERVENTIONS THAT INVOLVED ADULT PARTICIPANTS, REPORTED PREINTERVENTION AND POSTINTERVENTION BP, AND HAD A NONEXERCISE/NONDIET CONTROL GROUP. OUR SEARCH YIELDED 49 QUALIFYING CONTROLLED TRIALS (56 INTERVENTIONS). WE (1) EVALUATED THE RISK OF BIAS AND METHODOLOGICAL STUDY QUALITY, (2) PERFORMED META-REGRESSION ANALYSIS FOLLOWING RANDOM-EFFECTS ASSUMPTIONS, AND (3) GENERATED ADDITIVE MODELS THAT REPRESENTED THE LARGEST POSSIBLE CLINICALLY RELEVANT BP REDUCTIONS. RESULTS: ON AVERAGE, THE 3517 TRIAL PARTICIPANTS WERE MIDDLE-AGED (49.2+/-19.5 YEARS), OVERWEIGHT (27.9+/-3.6 KG/M(2)) ADULTS WITH HIGH BP (SYSTOLIC BP, 129.3+/-13.3 MM HG; DIASTOLIC BP, 80.7+/-8.4 MM HG). YOGA WAS PRACTICED 4.8+/-3.4 SESSIONS PER WEEK FOR 59.2+/-25.0 MINUTES PER SESSION FOR 13.2+/-7.5 WEEKS. ON AVERAGE, YOGA ELICITED MODERATE REDUCTIONS IN SYSTOLIC BP (WEIGHTED MEAN EFFECT SIZE, -0.47; 95% CI, -0.62-0.32, -5.0 MM HG) AND DIASTOLIC BP (WEIGHTED MEAN EFFECT SIZE, -0.47; 95% CI, -0.61 TO -0.32; -3.9 MM HG) COMPARED WITH CONTROLS (P<.001 FOR BOTH SYSTOLIC BP AND DIASTOLIC BP). CONTROLLING FOR PUBLICATION BIAS AND METHODOLOGICAL STUDY QUALITY, WHEN YOGA WAS PRACTICED 3 SESSIONS PER WEEK AMONG SAMPLES WITH HYPERTENSION, YOGA INTERVENTIONS THAT INCLUDED BREATHING TECHNIQUES AND MEDITATION/MENTAL RELAXATION ELICITED BP REDUCTIONS OF 11/6 MM HG COMPARED WITH THOSE THAT DID NOT (IE, 6/3 MM HG). CONCLUSION: OUR RESULTS INDICATE THAT YOGA IS A VIABLE ANTIHYPERTENSIVE LIFESTYLE THERAPY THAT PRODUCES THE GREATEST BP BENEFITS WHEN BREATHING TECHNIQUES AND MEDITATION/MENTAL RELAXATION ARE INCLUDED. 2019 4 1346 35 HYPERTENSION ANALYSIS OF STRESS REDUCTION USING MINDFULNESS MEDITATION AND YOGA: RESULTS FROM THE HARMONY RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THE HARMONY STUDY WAS A RANDOMIZED, CONTROLLED TRIAL EXAMINING THE EFFICACY OF AN 8-WEEK MINDFULNESS-BASED STRESS REDUCTION (MBSR) PROGRAM FOR BLOOD PRESSURE (BP) LOWERING AMONG UNMEDICATED STAGE 1 HYPERTENSIVE PARTICIPANTS. METHODS: PARTICIPANTS DIAGNOSED WITH STAGE 1 HYPERTENSION BASED ON AMBULATORY BP WERE RANDOMIZED TO EITHER IMMEDIATE TREATMENT OF MBSR FOR 8 WEEKS OR WAIT-LIST CONTROL. PRIMARY OUTCOME ANALYSIS EVALUATED WHETHER CHANGE IN AWAKE AND 24-HOUR AMBULATORY BP FROM BASELINE TO WEEK 12 WAS SIGNIFICANTLY DIFFERENT BETWEEN THE 2 GROUPS. A WITHIN-GROUP BEFORE AND AFTER MBSR ANALYSIS WAS ALSO PERFORMED. RESULTS: THE STUDY ENROLLED 101 ADULTS (38% MALE) WITH BASELINE AVERAGE 24-HOUR AMBULATORY BP OF 135+/-7.9/82+/-5.8MM HG AND DAYTIME AMBULATORY BP OF 140+/-7.7/87+/-6.3 MMHG. AT WEEK 12, THE CHANGE FROM BASELINE IN 24-HOUR AMBULATORY BP WAS 0.4+/-6.7/0.0+/-4.9MM HG FOR THE IMMEDIATE INTERVENTION AND 0.4+/-7.8/-0.4+/-4.6MM HG FOR THE WAIT-LIST CONTROL. THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN INTERVENTION AND WAIT-LIST CONTROL FOR ALL AMBULATORY BP PARAMETERS. THE SECONDARY WITHIN-GROUP ANALYSIS FOUND A SMALL REDUCTION IN BP AFTER MBSR COMPARED WITH BASELINE, A FINDING LIMITED TO FEMALE SUBJECTS IN A SEX ANALYSIS. CONCLUSIONS: MBSR DID NOT LOWER AMBULATORY BP BY A STATISTICALLY OR CLINICALLY SIGNIFICANT AMOUNT IN UNTREATED, STAGE 1 HYPERTENSIVE PATIENTS WHEN COMPARED WITH A WAIT-LIST CONTROL GROUP. IT LEAVES UNTESTED WHETHER MBSR MIGHT BE USEFUL FOR LOWERING BP BY IMPROVING ADHERENCE IN TREATED HYPERTENSIVE PARTICIPANTS. CLINICAL TRIALS REGISTRATION: NCT00825526. 2014 5 1855 24 RANDOMISED CONTROLLED TRIAL OF YOGA AND BIO-FEEDBACK IN MANAGEMENT OF HYPERTENSION. 34 HYPERTENSIVE PATIENTS WERE ASSIGNED AT RANDOM EITHER TO SIX WEEKS' TREATMENT BY YOGA RELAXATION METHODS WITH BIO-FEEDBACK OR TO PLACEBO THERAPY (GENERAL RELAXATION). BOTH GROUPS SHOWED A REDUCTION IN BLOOD-PRESSURE (FROM 168/100 TO 141/84 MM. HG IN THE TREATED GROUP AND FROM 169/101 TO 160/96 MM HG IN THE CONTROL GROUP). THE DIFFERENCE WAS HIGHLY SIGNIFICANT. THE CONTROL GROUP WAS THEN TRAINED IN YOGA RELAXATION, AND THEIR BLOOD-PRESSURE FELL TO THAT OF THE OTHER GROUP (NOW USED AS CONTROLS). 1975 6 221 38 A SYSTEMATIC REVIEW AND META-ANALYSIS OF YOGA FOR HYPERTENSION. BACKGROUND: THE AIM OF THIS SYSTEMATIC REVIEW AND META-ANALYSIS WAS TO EVALUATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATION FOR YOGA AS A THERAPEUTIC MEANS IN THE MANAGEMENT OF PREHYPERTENSION AND HYPERTENSION. METHODS: MEDLINE/PUBMED, SCOPUS, CENTRAL, AND INDMED WERE SCREENED THROUGH FEBRUARY 2014 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) ON THE EFFECTS OF YOGA INTERVENTIONS (>/=8 WEEKS) COMPARED WITH USUAL CARE OR ANY ACTIVE CONTROL INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION (120-139/80-89 MM HG) OR HYPERTENSION (>/=140/>/=90 MM HG). RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL; QUALITY OF EVIDENCE WAS ASSESSED ACCORDING TO THE GRADE RECOMMENDATIONS. RESULTS: SEVEN RCTS WITH A TOTAL OF 452 PATIENTS WERE INCLUDED. COMPARED WITH USUAL CARE, VERY LOW-QUALITY EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC (6 RCTS, N = 278; MEAN DIFFERENCE (MD) = -9.65 MM HG, 95% CONFIDENCE INTERVAL (CI) = -17.23 TO -2.06, P = 0.01; HETEROGENEITY: I (2) = 90%, CHI(2) = 48.21, P < 0.01) AND DIASTOLIC BLOOD PRESSURE (6 RCTS, N = 278; MD = -7.22 MM HG, 95% CI = -12.83 TO -1.62, P = 0.01; HETEROGENEITY: I (2) = 92%, CHI(2) = 64.84, P < 0.01). SUBGROUP ANALYSES REVEALED EFFECTS FOR RCTS THAT INCLUDED HYPERTENSIVE PATIENTS BUT NOT FOR RCTS THAT INCLUDED BOTH HYPERTENSIVE AND PREHYPERTENSIVE PATIENTS, AS WELL AS FOR RCTS THAT ALLOWED ANTIHYPERTENSIVE COMEDICATION BUT NOT FOR THOSE THAT DID NOT. MORE ADVERSE EVENTS OCCURRED DURING YOGA THAN DURING USUAL CARE. COMPARED WITH EXERCISE, NO EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC OR DIASTOLIC BLOOD PRESSURE. CONCLUSIONS: LARGER STUDIES ARE REQUIRED TO CONFIRM THE EMERGING BUT LOW-QUALITY EVIDENCE THAT YOGA MAY BE A USEFUL ADJUNCT INTERVENTION IN THE MANAGEMENT OF HYPERTENSION. 2014 7 166 31 A RANDOMIZED CONTROL TRIAL TO STUDY THE EFFECT OF INTEGRATED YOGA ON PREGNANCY OUTCOME IN HYPERTENSIVE DISORDER OF PREGNANCY. OBJECTIVE: THE STUDY AIMED TO EVALUATE THE EFFECTS OF INTEGRATED YOGA ON BLOOD PRESSURE AND PREGNANCY OUTCOME IN HYPERTENSIVE DISORDER OF PREGNANCY. METHODS: SEVENTY-NINE PATIENTS WERE RANDOMIZED INTO STUDY AND CONTROL GROUPS. THE STUDY GROUP RECEIVED THE INTERVENTION IN THE FORM OF INTEGRATED YOGA FOR 4 WEEKS. FINAL ANALYSIS WAS DONE ON 30 PATIENTS EACH OF STUDY AND CONTROL GROUP. RESULTS: THE MEAN SYSTOLIC BP DECLINED BY 7.43 +/- 5.86 MMHG IN THE STUDY GROUP AS COMPARED TO 2.50 +/- 5.21 MM HG IN THE CONTROL GROUP (P VALUE 0.002). THE MEAN DIASTOLIC BP PRIOR TO DELIVERY WAS 88.00 +/- 3.71 MMHG IN THE STUDY GROUP AND 92.20 +/- 5.02 MMHG IN THE CONTROL GROUP (P = 0.001). THE MATERNAL COMFORT IN LABOR WAS SIGNIFICANTLY HIGHER AND THE DURATION OF LABOR SIGNIFICANTLY REDUCED IN THE STUDY GROUP. CONCLUSION: INTEGRATED YOGA EFFECTIVELY REDUCED SYSTOLIC AND DIASTOLIC BLOOD PRESSURES AND INCREASED MATERNAL COMFORT DURING LABOR IN HYPERTENSIVE DISORDER OF PREGNANCY. 2021 8 2759 34 YOGA PRACTITIONERS EXHIBIT HIGHER PARASYMPATHETIC ACTIVITY AND BAROREFLEX SENSITIVITY AND BETTER ADAPTABILITY TO 40 MM HG LOWER-BODY NEGATIVE PRESSURE. YOGA HAS BEEN SHOWN TO IMPROVE AUTONOMIC CONDITIONING IN HUMANS, AS EVIDENCED BY THE ENHANCEMENT OF PARASYM-PATHETIC ACTIVITY AND BAROREFLEX SENSITIVITY. THEREFORE, WE HYPOTHESIZED THAT THE EXPERIENCE OF YOGA MAY RESULT IN ADAPTATION TO ACUTE HEMODYNAMIC CHANGES. TO DECIPHER THE LONG-TERM EFFECTS OF YOGA ON CARDIOVASCULAR VARIABILITY, YOGA PRACTITIONERS WERE COMPARED TO YOGA-NAIVE SUBJECTS DURING EXPOSURE TO -40 MM HG LOWER-BODY NEGATIVE PRESSURE (LBNP). A COMPARATIVE STUDY WAS CONDUCTED ON 40 YOGANAIVE SUBJECTS AND 40 YOGA PRACTITIONERS WITH AN AVERAGE AGE OF 31.08 +/- 7.31 YEARS AND 29.93 +/- 7.57 YEARS, RESPECTIVELY. HEART RATE VARIABILITY, BLOOD PRESSURE VARIABILITY, BAROREFLEX SENSITIVITY, AND CORRELATION BETWEEN SYSTOLIC BLOOD PRESSURE AND RR INTERVAL WERE EVALUATED AT REST AND DURING LBNP. IN YOGA PRACTITIONERS, THE HEART RATE WAS LOWER IN SUPINE REST (P = 0.011) AND DURING LBNP (P = 0.043); THE PNN50 MEASURE OF HEART RATE VARIABILITY WAS HIGHER IN SUPINE REST (P = 0.011) AND DURING LBNP (P = 0.034). THE YOGA PRACTITIONERS' STANDARD DEVIATION OF SUCCESSIVE BEAT-TO-BEAT BLOOD PRESSURE INTERVALS OF SYSTOLIC BLOOD PRESSURE VARIABILITY WAS LOWER IN SUPINE REST (P = 0.034) AND DURING LBNP (P = 0.007), WITH HIGHER SEQUENCE BAROREFLEX SENSITIVITY (P = 0.019) AND ~ HIGH-FREQUENCY BAROREFLEX SENSITIVITY. MEAN SYSTOLIC BLOOD PRESSURE AND RR INTERVAL WERE INVERSELY CORRELATED IN THE YOGA GROUP (R = -0.317, P = 0.049). THE YOGA PRACTITIONERS EXHIBITED HIGHER PARASYMPATHETIC ACTIVITY AND BAROREFLEX SENSITIVITY WITH LOWER SYSTOLIC BLOOD PRESSURE VARIABILITY, INDICATING BETTER ADAPTABILITY TO LBNP COMPARED TO THE YOGA-NAIVE GROUP. OUR FINDINGS INDICATE THAT THE YOGA MODULE WAS HELPFUL IN CONDITIONS OF HYPOVOLEMIA IN HEALTHY SUBJECTS; IT IS PROPOSED TO BE BENEFICIAL IN CLINICAL CONDITIONS ASSOCIATED WITH SYMPATHETIC DOMINANCE, IMPAIRED BARORE-FLEX SENSITIVITY, AND ORTHOSTATIC INTOLERANCE. 2021 9 1033 23 EFFECTS OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS. AIMS/INTRODUCTION: A META-ANALYSIS WAS CARRIED OUT TO EVALUATE THE EFFICACY OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: THE PUBMED, EMBASE AND COCHRANE DATABASES WERE SEARCHED TO OBTAIN ELIGIBLE RANDOMIZED CONTROLLED TRIALS. THE PRIMARY OUTCOME WAS FASTING BLOOD GLUCOSE, AND THE SECONDARY OUTCOMES INCLUDED GLYCOSYLATED HEMOGLOBIN A1C, TOTAL CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, TRIGLYCERIDE AND POSTPRANDIAL BLOOD GLUCOSE. WEIGHTED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED. THE I(2) STATISTIC REPRESENTED HETEROGENEITY. RESULTS: A TOTAL OF 12 RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 864 PATIENTS MET THE INCLUSION CRITERIA. THE POOLED WEIGHTED MEAN DIFFERENCES WERE -23.72 MG/DL (95% CI -37.78 TO -9.65; P = 0.001; I(2) = 82%) FOR FASTING BLOOD GLUCOSE AND -0.47% (95% CI -0.87 TO -0.07; P = 0.02; I(2) = 82%) FOR HEMOGLOBIN A1C. THE WEIGHTED MEAN DIFFERENCES WERE -17.38 MG/DL (95% CI -27.88 TO -6.89; P = 0.001; I(2) = 0%) FOR POSTPRANDIAL BLOOD GLUCOSE, -18.50 MG/DL (95% CI -29.88 TO -7.11; P = 0.001; I(2) = 75%) FOR TOTAL CHOLESTEROL, 4.30 MG/DL (95% CI 3.25 TO 5.36; P < 0.00001; I(2) = 10%) FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, -12.95 MG/DL (95% CI -18.84 TO -7.06; P < 0.0001; I(2) = 37%) FOR LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND -12.57 MG/DL (95% CI -29.91 TO 4.76; P = 0.16; I(2) = 48%) FOR TRIGLYCERIDES. CONCLUSIONS: THE AVAILABLE EVIDENCE SUGGESTS THAT YOGA BENEFITS ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS. HOWEVER, CONSIDERING THE LIMITED METHODOLOGY AND THE POTENTIAL HETEROGENEITY, FURTHER STUDIES ARE NECESSARY TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN TYPE 2 DIABETES MELLITUS PATIENTS. 2017 10 2007 27 STUDY OF YOGA ASANAS IN ASSESSMENT OF PULMONARY FUNCTION IN NIDDM PATIENTS. CERTAIN YOGA ASANAS IF PRACTICED REGULARLY ARE KNOWN TO HAVE BENEFICIAL EFFECTS ON HUMAN BODY. THESE YOGA PRACTICES MIGHT BE INTERACTING WITH VARIOUS, SOMATO-NEURO-ENDOCRINE MECHANISMS TO HAVE THERAPEUTIC EFFECTS. THE PRESENT STUDY DONE IN TWENTY FOUR NIDDM PATIENTS OF 30 TO 60 YEAR OLD, PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH PULMONARY FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND WERE PURSED 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS (BASAL 190.08 +/- 90.8 IN MG/DL TO 141.5 +/- 79.8 IN MG/DL). THE POSTPRANDIAL BLOOD GLUCOSE LEVELS ALSO DECREASED (276.54 +/- 101.0 IN MG/DL TO 201.75 +/- 104.1 IN MG/DL), GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE (9.03 +/- 1.4% TO 7.83 +/- 2.6%). THE FEV1, FVC, PEFR, MVV INCREASED SIGNIFICANTLY (1.81 +/- 0.4 LT TO 2.08 +/- 0.4 LT, 2.20 +/- 0.6 LT TO 2.37 +/- 0.5 LT, 3.30 +/- 1.0 LT/S TO 4.43 +/- 1.4 LT/S AND 64.59 +/- 25.7 LT MIN TO 76.28 +/- 28.1 LT/MIN RESPECTIVELY). FEV1/FVC% IMPROVED (85 +/- 0.2% TO 89 +/- 0.1%). THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS CAN BE OBTAINED IN NIDDM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING, INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND PULMONARY FUNCTIONS REMAINS TO BE WORKED OUT. 2002 11 1053 36 EFFECTS OF YOGA ON CARDIOVASCULAR DISEASE RISK FACTORS: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND META-ANALYZE THE EFFECTS OF YOGA ON MODIFIABLE BIOLOGICAL CARDIOVASCULAR DISEASE RISK FACTORS IN THE GENERAL POPULATION AND IN HIGH-RISK DISEASE GROUPS. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, AND INDMED WERE SCREENED THROUGH AUGUST 2013 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) ON YOGA FOR PREDEFINED CARDIOVASCULAR RISK FACTORS IN HEALTHY PARTICIPANTS, NON-DIABETIC PARTICIPANTS WITH HIGH RISK FOR CARDIOVASCULAR DISEASE, OR PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. RESULTS: FORTY-FOUR RCTS WITH A TOTAL OF 3168 PARTICIPANTS WERE INCLUDED. RISK OF BIAS WAS HIGH OR UNCLEAR FOR MOST RCTS. RELATIVE TO USUAL CARE OR NO INTERVENTION, YOGA IMPROVED SYSTOLIC (MEAN DIFFERENCE (MD)=-5.85 MM HG; 95% CONFIDENCE INTERVAL (CI)=-8.81, -2.89) AND DIASTOLIC BLOOD PRESSURE (MD=-4.12 MM HG; 95%CI=-6.55, -1.69), HEART RATE (MD=-6.59 BPM; 95%CI=-12.89, -0.28), RESPIRATORY RATE (MD=-0.93 BREATHS/MIN; 95%CI=-1.70, -0.15), WAIST CIRCUMFERENCE (MD=-1.95 CM; 95%CI=-3.01, -0.89), WAIST/HIP RATIO (MD=-0.02; 95%CI=-0.03, -0.00), TOTAL CHOLESTEROL (MD=-13.09 MG/DL; 95%CI=-19.60, -6.59), HDL (MD=2.94 MG/DL; 95%CI=0.57, 5.31), VLDL (MD=-5.70 MG/DL; 95%CI=-7.36, -4.03), TRIGLYCERIDES (MD=-20.97 MG/DL; 95%CI=-28.61, -13.32), HBA1C (MD=-0.45%; 95%CI=-0.87, -0.02), AND INSULIN RESISTANCE (MD=-0.19; 95%CI=-0.30, -0.08). RELATIVE TO EXERCISE, YOGA IMPROVED HDL (MD=3.70 MG/DL; 95%CI=1.14, 6.26). CONCLUSIONS: THIS META-ANALYSIS REVEALED EVIDENCE FOR CLINICALLY IMPORTANT EFFECTS OF YOGA ON MOST BIOLOGICAL CARDIOVASCULAR DISEASE RISK FACTORS. DESPITE METHODOLOGICAL DRAWBACKS OF THE INCLUDED STUDIES, YOGA CAN BE CONSIDERED AS AN ANCILLARY INTERVENTION FOR THE GENERAL POPULATION AND FOR PATIENTS WITH INCREASED RISK OF CARDIOVASCULAR DISEASE. 2014 12 174 29 A RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFECTS OF YOGA WITH AN ACTIVE CONTROL ON AMBULATORY BLOOD PRESSURE IN INDIVIDUALS WITH PREHYPERTENSION AND STAGE 1 HYPERTENSION. THE PURPOSE OF THIS STUDY WAS TO COMPARE THE EFFECTS OF YOGA WITH AN ACTIVE CONTROL (NONAEROBIC EXERCISE) IN INDIVIDUALS WITH PREHYPERTENSION AND STAGE 1 HYPERTENSION. A RANDOMIZED CLINICAL TRIAL WAS PERFORMED USING TWO ARMS: (1) YOGA AND (2) ACTIVE CONTROL. PRIMARY OUTCOMES WERE 24-HOUR DAY AND NIGHT AMBULATORY SYSTOLIC AND DIASTOLIC BLOOD PRESSURES. WITHIN-GROUP AND BETWEEN-GROUP ANALYSES WERE PERFORMED USING PAIRED T TESTS AND REPEATED-MEASURES ANALYSIS OF VARIANCE (TIME X GROUP), RESPECTIVELY. EIGHTY-FOUR PARTICIPANTS ENROLLED, WITH 68 PARTICIPANTS COMPLETING THE TRIAL. WITHIN-GROUP ANALYSES FOUND 24-HOUR DIASTOLIC, NIGHT DIASTOLIC, AND MEAN ARTERIAL PRESSURE ALL SIGNIFICANTLY REDUCED IN THE YOGA GROUP (-3.93, -4.7, -4.23 MM HG, RESPECTIVELY) BUT NO SIGNIFICANT WITHIN-GROUP CHANGES IN THE ACTIVE CONTROL GROUP. DIRECT COMPARISONS OF THE YOGA INTERVENTION WITH THE CONTROL GROUP FOUND A SINGLE BLOOD PRESSURE VARIABLE (DIASTOLIC NIGHT) TO BE SIGNIFICANTLY DIFFERENT (P=.038). THIS STUDY HAS DEMONSTRATED THAT A YOGA INTERVENTION CAN LOWER BLOOD PRESSURE IN PATIENTS WITH MILD HYPERTENSION. ALTHOUGH THIS STUDY WAS NOT ADEQUATELY POWERED TO SHOW BETWEEN-GROUP DIFFERENCES, THE SIZE OF THE YOGA-INDUCED BLOOD PRESSURE REDUCTION APPEARS TO JUSTIFY PERFORMING A DEFINITIVE TRIAL OF THIS INTERVENTION TO TEST WHETHER IT CAN PROVIDE MEANINGFUL THERAPEUTIC VALUE FOR THE MANAGEMENT OF HYPERTENSION. 2014 13 814 35 EFFECT OF YOGA ON CARDIOVASCULAR SYSTEM IN SUBJECTS ABOVE 40 YEARS. THIS STUDY WAS CONDUCTED TO EXAMINE THE EFFECT OF YOGA ON CARDIOVASCULAR FUNCTION IN SUBJECTS ABOVE 40 YRS OF AGE. PULSE RATE, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE AND VALSALVA RATIO WERE STUDIED IN 50 CONTROL SUBJECTS (NOT DOING ANY TYPE OF PHYSICAL EXERCISE) AND 50 STUDY SUBJECTS WHO HAD BEEN PRACTICING YOGA FOR 5 YEARS. FROM THE STUDY IT WAS OBSERVED THAT SIGNIFICANT REDUCTION IN THE PULSE RATE OCCURS IN SUBJECTS PRACTICING YOGA (P<0.001). THE DIFFERENCE IN THE MEAN VALUES OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE BETWEEN STUDY GROUP AND CONTROL GROUP WAS ALSO STATISTICALLY SIGNIFICANT (P<0.01 AND P<0.001 RESPECTIVELY). THE SYSTOLIC AND DIASTOLIC BLOOD PRESSURE SHOWED SIGNIFICANT POSITIVE CORRELATION WITH AGE IN THE STUDY GROUP (R1 SYSTOLIC= 0.631 AND R1 DIASTOLIC = 0.610) AS WELL AS IN THE CONTROL GROUP (R2 SYSTOLIC = 0.981 AND R2 DIASTOLIC = 0.864). THE SIGNIFICANCE OF DIFFERENCE BETWEEN CORRELATION COEFFICIENT OF BOTH THE GROUPS WAS ALSO TESTED WITH THE USE OF Z TRANSFORMATION AND THE DIFFERENCE WAS SIGNIFICANT (Z SYSTOLIC= 4.041 AND Z DIASTOLIC= 2.901). VALSALVA RATIO WAS ALSO FOUND TO BE SIGNIFICANTLY HIGHER IN YOGA PRACTITIONERS THAN IN CONTROLS (P<0.001). OUR RESULTS INDICATE THAT YOGA REDUCES THE AGE RELATED DETERIORATION IN CARDIOVASCULAR FUNCTIONS. 2003 14 31 14 12-MONTH FOLLOW-UP OF YOGA AND BIO-FEEDBACK IN THE MANAGEMENT OF HYPERTENSION. TWENTY HYPERTENSIVE PATIENTS TREATED BY PSYCHOPHYSICAL RELAXATION EXERCISES WERE FOLLOWED UP MONTHLY FOR 12 MONTHS. AGE AND SEX MATCHED HYPERTENSIVE CONTROLS WERE SIMILARLY FOLLOWED UP FOR 9 MONTHS. STATISTICALLY SIGNIFICANT REDUCTIONS IN BLOOD-PRESSURE (BP) AND ANTIHYPERTENSIVE DRUG REQUIREMENTS WERE SATISFACTORILY MAINTAINED IN THE TREATMENT GROUP. MERE REPETITION OF B.P. MEASUREMENTS AND INCREASED MEDICAL ATTENTION DID NOT IN THEMSELVES REDUCE B.P. SIGNIFICANTLY IN CONTROL PATIENTS. 1975 15 1499 27 INTRAOCULAR PRESSURE RISE IN SUBJECTS WITH AND WITHOUT GLAUCOMA DURING FOUR COMMON YOGA POSITIONS. PURPOSE: TO MEASURE CHANGES IN INTRAOCULAR PRESSURE (IOP) IN ASSOCIATION WITH YOGA EXERCISES WITH A HEAD-DOWN POSITION. METHODS: THE SINGLE CENTER, PROSPECTIVE, OBSERVATIONAL STUDY INCLUDED 10 SUBJECTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND 10 NORMAL INDIVIDUALS, WHO PERFORMED THE YOGA EXERCISES OF ADHO MUKHA SVANASANA, UTTANASANA, HALASANA AND VIPARITA KARANI FOR TWO MINUTES EACH. IOP WAS MEASURED BY PNEUMATONOMETRY AT BASELINE AND DURING AND AFTER THE EXERCISES. RESULTS: ALL YOGA POSES WERE ASSOCIATED WITH A SIGNIFICANT (P < 0.01) RISE IN IOP WITHIN ONE MINUTE AFTER ASSUMING THE YOGA POSITION. THE HIGHEST IOP INCREASE (P < 0.01) WAS MEASURED IN THE ADHO MUKHA SVANASANA POSITION (IOP INCREASE FROM 17 +/- 3.2 MMHG TO 28 +/- 3.8 MMHG IN GLAUCOMA PATIENTS; FROM 17 +/- 2.8 MMHG TO 29 +/- 3.9 MMHG IN NORMAL INDIVIDUALS), FOLLOWED BY THE UTTANASANA POSITION (17 +/- 3.9 MMHG TO 27 +/- 3.4 MMHG (GLAUCOMA PATIENTS) AND FROM 18 +/- 2.5 MMHG TO 26 +/- 3.6 MMHG NORMAL INDIVIDUALS)), THE HALASANA POSITION (18 +/- 2.8 MMHG TO 24 +/- 3.5 MMHG (GLAUCOMA PATIENTS); 18 +/- 2.7 MMHG TO 22 +/- 3.4 MMHG (NORMAL INDIVIDUALS)), AND FINALLY THE VIPARITA KIRANI POSITION (17 +/- 4 MMHG TO 21 +/- 3.6 MMHG (GLAUCOMA PATIENTS); 17 +/- 2.8 TO 21 +/- 2.4 MMHG (NORMAL INDIVIDUALS)). IOP DROPPED BACK TO BASELINE VALUES WITHIN TWO MINUTES AFTER RETURNING TO A SITTING POSITION. OVERALL, IOP RISE WAS NOT SIGNIFICANTLY DIFFERENT BETWEEN GLAUCOMA AND NORMAL SUBJECTS (P = 0.813), ALL THOUGH GLAUCOMA EYES TENDED TO HAVE MEASUREMENTS 2 MM HG HIGHER ON AVERAGE. CONCLUSIONS: YOGA EXERCISES WITH HEAD-DOWN POSITIONS WERE ASSOCIATED WITH A RAPID RISE IN IOP IN GLAUCOMA AND HEALTHY EYES. IOP RETURNED TO BASELINE VALUES WITHIN 2 MINUTES. FUTURE STUDIES ARE WARRANTED ADDRESSING WHETHER YOGA EXERCISE ASSOCIATED IOP CHANGES ARE ASSOCIATED WITH SIMILAR CHANGES IN CEREBROSPINAL FLUID PRESSURE AND WHETHER THEY INCREASE THE RISK OF GLAUCOMA PROGRESSION. TRIAL REGISTRATION: CLINICALTRIALS.GOV #NCT01915680. 2015 16 1533 37 IYENGAR YOGA VERSUS ENHANCED USUAL CARE ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION TO STAGE I HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL. THE PREVALENCE OF PREHYPERTENSION AND STAGE 1 HYPERTENSION CONTINUES TO INCREASE DESPITE BEING AMENABLE TO NON-PHARMACOLOGIC INTERVENTIONS. IYENGAR YOGA (IY) HAS BEEN PURPORTED TO REDUCE BLOOD PRESSURE (BP) THOUGH EVIDENCE FROM RANDOMIZED TRIALS IS LACKING. WE CONDUCTED A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTS OF 12 WEEKS OF IY VERSUS ENHANCED USUAL CARE (EUC) (BASED ON INDIVIDUAL DIETARY ADJUSTMENT) ON 24-H AMBULATORY BP IN YOGA-NAIVE ADULTS WITH UNTREATED PREHYPERTENSION OR STAGE 1 HYPERTENSION. IN TOTAL, 26 AND 31 SUBJECTS IN THE IY AND EUC ARMS, RESPECTIVELY, COMPLETED THE STUDY. THERE WERE NO DIFFERENCES IN BP BETWEEN THE GROUPS AT 6 AND 12 WEEKS. IN THE EUC GROUP, 24-H SYSTOLIC BP (SBP), DIASTOLIC BP (DBP) AND MEAN ARTERIAL PRESSURE (MAP) SIGNIFICANTLY DECREASED BY 5, 3 AND 3 MMHG, RESPECTIVELY, FROM BASELINE AT 6 WEEKS (P < .05), BUT WERE NO LONGER SIGNIFICANT AT 12 WEEKS. IN THE IY GROUP, 24 H SBP WAS REDUCED BY 6 MMHG AT 12 WEEKS COMPARED TO BASELINE (P = .05). 24 H DBP (P < .01) AND MAP (P < .05) DECREASED SIGNIFICANTLY EACH BY 5 MMHG. NO DIFFERENCES WERE OBSERVED IN CATECHOLAMINE OR CORTISOL METABOLISM TO EXPLAIN THE DECREASE IN BP IN THE IY GROUP AT 12 WEEKS. TWELVE WEEKS OF IY PRODUCES CLINICALLY MEANINGFUL IMPROVEMENTS IN 24 H SBP AND DBP. LARGER STUDIES ARE NEEDED TO ESTABLISH THE LONG TERM EFFICACY, ACCEPTABILITY, UTILITY AND POTENTIAL MECHANISMS OF IY TO CONTROL BP. 2011 17 2153 21 THE EFFECTS OF SUDARSHAN KRIYA YOGA ON SOME PHYSIOLOGICAL AND BIOCHEMICAL PARAMETERS IN MILD HYPERTENSIVE PATIENTS. AN OPEN LABEL INTERVENTION STUDY WAS UNDERTAKEN ON 26 MILD HYPERTENSIVES AND 26 APPARENTLY HEALTHY ADULTS (30-60 Y), FOR THE EFFECT OF SUDARSHAN KRIYA YOGA PRACTICE FOR TWO MONTHS AS COMPLEMENTARY THERAPY. IN THE HYPERTENSIVES, THERE WAS A SIGNIFICANT DECREASE IN DIASTOLIC BLOOD PRESSURE (P < 0.01), SERUM UREA (P < 0.01) AND PLASMA MDA (MALONDIALDEHYDE ADDUCTS) AS OXIDATIVE STRESS MARKER (P < 0.05). OTHER PARAMETERS; VIZ.; PLASMA LEVELS OF CHOLESTEROL, TRIGLYCERIDES, GLUCOSE, DID NOT CHANGE SIGNIFICANTLY (P > 0.1). THE PATTERN OF CHANGE IN MOST OF THE STUDY PARAMETERS WAS SUCH THAT VALUES ABOVE NORMAL RANGE WERE LOWERED BUT VALUES WITHIN NORMAL RANGE WERE UNALTERED. THE ACTION OF YOGA ON DIASTOLIC BLOOD PRESSURE, MALONDIALDEHYDE ADDUCTS AND KIDNEY FUNCTION IN HYPERTENSIVES WAS OF COUNTERACTIVE NATURE AND FELT TO BE DISTINCTLY DIFFERENT THAN THE EFFECT OF DRUGS. 2011 18 2463 39 YOGA AS A THERAPEUTIC INTERVENTION FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PURPOSE: THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF 12 WEEKS YOGIC INTERVENTION ON BLOOD SUGAR AND LIPID PROFILE IN ELDER WOMEN WITH TYPE 2 DIABETES MELLITUS (T2DM). SUBJECTS AND METHODS: TWENTY ELDERLY (AGE RANGE 55-70 YEARS) T2DM WOMEN WERE DIVIDED INTO TWO GROUPS, NAMELY, YOGIC INTERVENTION GROUP (YIG: N = 10, AGE 64.70 +/- 4.03, BODY MASS INDEX [BMI] 24.26 +/- 3.40) AND CONTROL GROUP (CG: N = 10, AGE 64.40 +/- 4.79, BMI 24.28 +/- 2.36). YIG UNDERWENT YOGA PRACTICE (ASANAS, KRIYAS, PRANAYAMAS) FOR 12 WEEKS (3 SESSIONS/WEEK), WHILE THE CG CONTINUED THEIR USUAL ROUTINE ACTIVITIES. STANDING HEIGHT, BODY WEIGHT, BMI, BLOOD SUGAR, AND LIPID PROFILE WERE MEASURED BEFORE COMMENCEMENT AND AFTER 6 AND 12 WEEKS OF YOGIC INTERVENTION IN BOTH GROUPS. RESULTS: THERE WAS A SIGNIFICANT (P < 0.01) DECREASE IN FASTING PLASMA GLUCOSE, POSTPRANDIAL BLOOD SUGAR, TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND VERY LOW DENSITY LIPOPROTEIN, WITH A SIGNIFICANT (P < 0.01) INCREASE IN HIGH-DENSITY LIPOPROTEIN LEVEL FROM ITS INITIAL VALUE IN YIG, WHILE SHOWING INSIGNIFICANT RESULT IN CG. CONCLUSION: IT CAN BE SAID THAT YOGIC INTERVENTION MAY HAVE THE BENEFICIAL EFFECTS ON BLOOD SUGAR AND LIPID PROFILE IN ELDERLY WOMEN WITH T2DM. 2018 19 2118 44 THE EFFECT OF YOGA PRACTICE ON GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS IN THE PREDIABETIC STATE: A SYSTEMATIC REVIEW AND META-ANALYSIS. A SYSTEMATIC REVIEW AND META-ANALYSIS WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON GLYCEMIC CONTROL, LIPID PROFILES, BODY COMPOSITION AND BLOOD PRESSURE IN PEOPLE IN THE PRE-DIABETIC STATE. STUDIES ON THE EFFECTIVENESS OF YOGA ON POPULATION GROUPS UNDER HIGH RISK FOR DIABETES, CALLED PREDIABETIC OR SUFFERING FROM METABOLIC SYNDROMES WERE EXTRACTED FROM A THOROUGH SEARCH OF PUBMED, SCOPUS, COCHRANE LIBRARY, EBSCO AND INDMED DATABASES. BOTH RANDOMISED CONTROLLED TRIAL (RCT) AND NON-RCT STUDIES WERE INCLUDED IN THE SYSTEMATIC REVIEW AND META-ANALYSIS. STUDIES PUBLISHED BETWEEN JAN 2002 AND DEC 2018 WERE INCLUDED. STUDIES WERE CONSIDERED FOR EVALUATION IF THEY INVESTIGATED A YOGA INTERVENTION TO PREVENT T2DM, AGAINST A CONTROL GROUP, WHILE ALSO REPORTING GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS OF T2DM MANAGEMENT. SUMMARY EFFECT SIZES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING THE COMPREHENSIVE META-ANALYSIS SOFTWARE IN ADDITION TO PUBLICATION BIAS. OF THE 46,500 IDENTIFIED STUDIES, 14 STUDIES WITH 834 PARTICIPANTS OF WHOM WERE 50% WOMEN, WERE FOUND TO BE ELIGIBLE FOR INCLUSION IN OUR SYSTEMATIC REVIEW. OUR QUANTITATIVE SYNTHESIS INCLUDED 12 RANDOMIZED CONTROL TRIALS AND 2 NON-RANDOMIZED CONTROL TRIALS, WITH THE FOLLOW-UP PERIOD RANGING FROM 4 TO 52 WEEKS. COMPARED TO CONTROLS, YOGA INTERVENTION IMPROVED FASTING BLOOD GLUCOSE (FBG) [STANDARD MEAN DIFFERENCE (SMD -0.064 MG/DL (95% CI -0.201 TO 0.074)]; LOW DENSITY LIPOPROTEIN (LDL) [SMD-0.090 MG/DL (95% CI -0.270 TO 0.090)]; TRIGLYCERIDES [SMD -0.148 MG/DL (95% CI -0.285 TO -0.012)]; TOTAL CHOLESTEROL [SMD -0.058 MG/DL (95% CI -0.220 TO 0.104)] AND SYSTOLIC BLOOD PRESSURE [SMD -0.058 MM HG (95% CI -0.168 TO 0.053)]. THIS META-ANALYSIS UNCOVERED CLINICALLY IMPROVED EFFECTS OF YOGA INTERVENTION ON GLYCEMIC CONTROL, LIPID PROFILES AND OTHER PARAMETERS OF T2DM MANAGEMENT IN PREDIABETIC POPULATION. THESE RESULTS SUGGEST THAT YOGA INTERVENTION MAY BE CONSIDERED AS A COMPREHENSIVE AND ALTERNATIVE APPROACH TO PREVENTING T2DM. FURTHER ADEQUATELY POWERED, WELL DESIGNED RCTS ARE NEEDED TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN T2DM PATIENTS. 2019 20 412 34 BLOOD PRESSURE EFFECTS OF YOGA, ALONE OR IN COMBINATION WITH LIFESTYLE MEASURES: RESULTS OF THE LIFESTYLE MODIFICATION AND BLOOD PRESSURE STUDY (LIMBS). THE AUTHORS CONDUCTED A STUDY TO ASSESS THE EFFECTS OF YOGA ON BLOOD PRESSURE (BP). PATIENTS WERE RANDOMIZED TO YOGA (BLOOD PRESSURE EDUCATION PROGRAM [BPEP]), OR A COMBINED PROGRAM (COMBO). AMBULATORY BP WAS MEASURED AT BASELINE AND AT 12 AND 24 WEEKS. DATA ARE PRESENTED FOR ALL ENROLLED PATIENTS (N=137) AND FOR COMPLETERS ONLY (N=90). SYSTOLIC BP (SBP) AND DIASTOLIC BP (DBP) WERE SIGNIFICANTLY DECREASED WITHIN ALL GROUPS AT 12 AND 24 WEEKS (P<.001) FOR ENROLLED PATIENTS AND COMPLETERS. SBP WAS SIGNIFICANTLY REDUCED IN THE YOGA AND COMBO GROUPS AS COMPARED WITH THE BPEP GROUP AT 12 WEEKS IN ALL ENROLLED AND COMPLETERS. SBP DIFFERENCES WERE NO LONGER SIGNIFICANT AT 24 WEEKS BETWEEN GROUPS IN ALL ENROLLED PATIENTS; HOWEVER, THERE WAS A GREATER REDUCTION IN SBP AT 24 WEEKS IN COMPLETERS FAVORING BPEP OVER YOGA. NO DIFFERENCES IN DBP BETWEEN GROUPS OR IN BP BETWEEN THE YOGA AND COMBO GROUPS WERE PRESENT. THE AUTHORS DID NOT OBSERVE AN ADDITIVE BENEFIT FROM COMBINING YOGA WITH BPEP MEASURES. REASONS FOR THIS ARE UNCLEAR AT THIS TIME. BP LOWERING WITH YOGA, HOWEVER, WAS SIMILAR TO THAT ACHIEVED WITH LIFESTYLE MEASURES. 2016